U.S. markets open in 2 hours 10 minutes
  • S&P Futures

    3,788.50
    +26.25 (+0.70%)
     
  • Dow Futures

    30,905.00
    +185.00 (+0.60%)
     
  • Nasdaq Futures

    12,917.25
    +115.00 (+0.90%)
     
  • Russell 2000 Futures

    2,145.50
    +24.70 (+1.16%)
     
  • Crude Oil

    52.57
    +0.21 (+0.40%)
     
  • Gold

    1,841.00
    +11.10 (+0.61%)
     
  • Silver

    25.34
    +0.47 (+1.91%)
     
  • EUR/USD

    1.2133
    +0.0050 (+0.41%)
     
  • 10-Yr Bond

    1.0970
    0.0000 (0.00%)
     
  • Vix

    22.72
    -0.53 (-2.28%)
     
  • GBP/USD

    1.3617
    +0.0031 (+0.23%)
     
  • USD/JPY

    103.9370
    +0.2500 (+0.24%)
     
  • BTC-USD

    37,297.60
    +855.87 (+2.35%)
     
  • CMC Crypto 200

    738.51
    +3.36 (+0.46%)
     
  • FTSE 100

    6,729.48
    +8.83 (+0.13%)
     
  • Nikkei 225

    28,633.46
    +391.25 (+1.39%)
     

Medibank Private (ASX:MPL) Has Compensated Shareholders With A Respectable 72% Return On Their Investment

Simply Wall St
·3 min read

Generally speaking the aim of active stock picking is to find companies that provide returns that are superior to the market average. And the truth is, you can make significant gains if you buy good quality businesses at the right price. For example, long term Medibank Private Limited (ASX:MPL) shareholders have enjoyed a 39% share price rise over the last half decade, well in excess of the market return of around 24% (not including dividends).

Check out our latest analysis for Medibank Private

To paraphrase Benjamin Graham: Over the short term the market is a voting machine, but over the long term it's a weighing machine. One flawed but reasonable way to assess how sentiment around a company has changed is to compare the earnings per share (EPS) with the share price.

During five years of share price growth, Medibank Private achieved compound earnings per share (EPS) growth of 2.0% per year. This EPS growth is lower than the 7% average annual increase in the share price. So it's fair to assume the market has a higher opinion of the business than it did five years ago. And that's hardly shocking given the track record of growth.

You can see below how EPS has changed over time (discover the exact values by clicking on the image).

earnings-per-share-growth
earnings-per-share-growth

We like that insiders have been buying shares in the last twelve months. Having said that, most people consider earnings and revenue growth trends to be a more meaningful guide to the business. Dive deeper into the earnings by checking this interactive graph of Medibank Private's earnings, revenue and cash flow.

What About Dividends?

As well as measuring the share price return, investors should also consider the total shareholder return (TSR). The TSR incorporates the value of any spin-offs or discounted capital raisings, along with any dividends, based on the assumption that the dividends are reinvested. It's fair to say that the TSR gives a more complete picture for stocks that pay a dividend. We note that for Medibank Private the TSR over the last 5 years was 72%, which is better than the share price return mentioned above. The dividends paid by the company have thusly boosted the total shareholder return.

A Different Perspective

Investors in Medibank Private had a tough year, with a total loss of 3.3% (including dividends), against a market gain of about 3.7%. Even the share prices of good stocks drop sometimes, but we want to see improvements in the fundamental metrics of a business, before getting too interested. Longer term investors wouldn't be so upset, since they would have made 12%, each year, over five years. It could be that the recent sell-off is an opportunity, so it may be worth checking the fundamental data for signs of a long term growth trend. I find it very interesting to look at share price over the long term as a proxy for business performance. But to truly gain insight, we need to consider other information, too. Consider risks, for instance. Every company has them, and we've spotted 1 warning sign for Medibank Private you should know about.

There are plenty of other companies that have insiders buying up shares. You probably do not want to miss this free list of growing companies that insiders are buying.

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on AU exchanges.

This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.